What is the effect of Ezetimibe for APOE4 carriers?
Phoenix has measured Ezetimibe against 5 exact outcomes for APOE4 carriers. Member #29E727 lowered ApoB from 131 to 90 mg/dL in 133 days on an ezetimibe-led combination. Member #6FAEFA's HDL cholesterol moved from 74 to 89 mg/dL in 70 days. Three members lowered LDL cholesterol in windows where ezetimibe was the most mechanistically established component of a larger combination. The same three members' total cholesterol fell alongside their LDL cholesterol. Member #B50FCD's Triglycerides moved from 59.4 to 46.9 mg/dL in 85 days.